Teva Canada Limited

26 articles about Teva Canada Limited

• Teva Canada Announces the Launch of C ACT Methylphenidate ER Tablets

  3/22/2018

  Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for CACT Methylphenidate ER® tablets, the generic version of CConcerta® (methylphenidate hydrochloride).

• Doug Sommerville Of Teva Canada Elected Chair Of Canadian Generic Pharmaceutical Association

  10/2/2017

• Teva Canada Announces Publication Of ARM-TD Study Results In Neurology For The Investigational Use Of Deutetrabenazine In Tardive Dyskinesia

  4/27/2017

• Teva Canada Announces Launch Of Generic Epzicom Tablets In The United States

  9/30/2016

• Teva Canada Limited to Sell Quebec Plant and Transfer 150 Staff to US CMO

  3/29/2012

• Teva Canada Limited Invests $56 Million to Expand its Stouffville Production Plant; Will Retain 182 Workers and Hire 20 New Employees

  5/26/2010